Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A homozygous AHI1 gene mutation (p.Thr304AsnfsX6) in a consanguineous Moroccan family with Joubert syndrome: a case report

  • Siham Chafai-Elalaoui1, 2,
  • Matthias Chalon3,
  • Nadia Elkhartoufi4,
  • Yamna Kriouele5,
  • Maria Mansouri1, 2,
  • Tania Attié-Bitach4, 6, 7,
  • Abdelaziz Sefiani1, 2 and
  • Lekbir Baala3, 8Email author
Journal of Medical Case Reports20159:254

https://doi.org/10.1186/s13256-015-0732-3

Received: 18 December 2014

Accepted: 8 October 2015

Published: 5 November 2015

Abstract

Introduction

Joubert syndrome is a rare congenital disorder characterized by brain malformation, developmental delay with hypotonia, ocular motor apraxia, and breathing abnormalities. Joubert syndrome is a genetically highly heterogeneous ciliopathy disorder with 23 identified causative genes. The diagnosis is based on brain imaging showing the “molar tooth sign” with cerebellar vermis agenesis. We describe a consanguineous Moroccan family with three affected siblings (18-year-old boy, 13-year-old girl, and 10-year-old boy) showing typical signs of Joubert syndrome, and attempt to identify the underlying genetic defect in this family.

Methods

We performed genome-wide homozygosity mapping using a high-resolution array followed by targeted Sanger sequencing to identify the causative gene.

Results

This approach found three homozygous regions, one including the AHI1 gene. Direct sequencing of the 26 coding exons of AHI1 revealed a homozygous mutation (p.Thr304AsnfsX6) located in exon 7 present in the three Joubert syndrome-affected Moroccan siblings. Of more interest, this truncating mutation was previously reported in patients with compound heterozygous Joubert syndrome originating from Spain (one patient) and from the Netherlands (two patients), suggesting a possible founder effect or mutational hotspot.

Conclusions

Combined homozygosity mapping and targeted sequencing allowed the rapid detection of the disease-causing mutation in the AHI1 gene in this family affected with a highly genetically heterogeneous disorder. Carriers of the same truncating mutation (p.Thr304AsnfsX6), originating from Spain and the Netherlands, presented variable clinical characteristics, thereby corroborating the extreme heterogeneity of Joubert syndrome.

Keywords

AHI1 mutationHomozygosity mappingJoubert syndrome

Introduction

Joubert syndrome (JBTS; Mendelian Inheritance in Man, MIM #213300) is a rare congenital disorder characterized by a distinctive brain malformation, developmental delay with hypotonia, ocular motor apraxia, and breathing abnormalities [1]. The diagnosis is based on a characteristic feature of brain imaging, the “molar tooth sign” (MTS) reflecting agenesis of the cerebellar vermis, and brainstem alterations. The MTS has also been described in many syndromes included in the designation “Joubert syndrome and related disorders” (JSRDs) with involvement of several other organs including the eye, kidney, and liver [24]. JBTS is a genetically heterogeneous disorder. Thus far, 23 genes have been identified of which 22 are autosomal recessive and one is X-linked recessive.

Most genes causing JBTS encode proteins involved in primary cilia functions, thus JBTS is included in a group of disorders called ciliopathies. Mutations in several genes implicated in JBTS have been identified in other ciliopathies such as MORM syndrome (mental retardation, truncal obesity, retinal dystrophy, and micropenis; MIM #610156) [5] and nephronophthisis (NPHP; MIM #256100), Meckel syndrome (MIM #249000) [6, 7], and oral-facial-digital syndrome type 1 (OFD1; MIM #311200) or type 6 (MIM #277170), thus suggesting that various clinically distinct ciliopathies may be allelic. The considerable phenotypic overlap and wide variability of these ciliopathies can be explained by their common molecular and cellular etiology [8].

We describe here a consanguineous Moroccan family with three affected siblings (two boys and one girl) showing typical signs of JBTS with hypotonia, mental retardation, bilateral nystagmus, ataxia, retinitis pigmentosa and a MTS on brain magnetic resonance imaging (MRI). To identify the underlying genetic defect in this family, we performed a genome-wide homozygosity mapping using the high-resolution Affymetrix single nucleotide polymorphism (SNP) 6.0 array followed by direct sequencing.

Results

Clinical investigation

We describe a Moroccan family of three affected siblings born to healthy consanguineous parents (parents are first cousins; Fig. 1).
Fig. 1

Pedigree of Moroccan family with Joubert syndrome. Patients 1, 2 and 3 were 18-, 13- and 10-years old respectively. Their parents are first cousins

Patient 1, the first child, an 18-year-old boy, was referred to medical genetics for mental retardation and visual impairment. Born at term, he had neonatal hypotonia, and psychomotor delay, walked at 4 years of age and had very poor language skills. He had visual impairment, which was worse at night. He never attended school. Urea and creatinine measured in his blood were normal. On clinical examination, he had normal growth parameters, bilateral horizontal nystagmus, and ataxia. An ophthalmological examination showed retinitis pigmentosa. Brain MRI revealed a hypoplasia of his cerebellar vermis with a MTS (Fig. 2).
Fig. 2

Magnetic Resonance Imaging (MRI): Sagittal and axial views through brainstem of patient 1 indicating hypoplasia of cerebellar vermis (red stars a), horizontally oriented (red arrow, a) and elongated (black arrows, b) superior cerebellar peduncles forming the “molar tooth“ sign (headarrows, b and c)

Patient 2, a 13-year-old girl, had clinical findings similar to those of her older brother with psychomotor delay and poor language skills. She walked at 2 years of age.

Patient 3, an 10-year-old boy, had clinical findings similar to those of his older brother and sister. He also had psychomotor delay and very poor language skills, and walked at 3 years of age.

Molecular analysis

Homozygosity mapping performed using the high resolution Affymetrix SNP 6.0 array revealed three homozygous regions that were shared among affected siblings, with a size of 1.7 Mb at 5q33.3, 30.1 Mb at 14q22–24 and 28.9 Mb at 6q22.1–24 respectively. Overall, the three intervals contained more than 100 genes. We compared the detected homozygous regions with known JBTS loci, and found that the homozygous region on chromosome 6q contained Abelson helper integration site 1 (AHI1), considered to be the gene at JBST3 locus. Direct sequencing of the 26 coding exons revealed an insertion of an adenosine base (c.910dup, p.Thr304AsnfsX6), located in exon 7 (NM_017651.4), causing a frameshift and predicting a premature protein truncation. The mutation was homozygous in all patients (Fig. 3), heterozygous in their parents, and not found in controls with the same ethnic background. Otherwise, the genomic array analysis detected no pathological copy number variation (CNV) in particular at the nephronophthisis 1 (NPHP1) locus.
Fig. 3

Sequence analysis. The three patients carry a homozygous mutation (p.Thr304AsnfsX6) causing frameshift and predicting a premature protein truncation (a : affected daughter or patient 2, b: affected son or patient 1). Parents are heterozygous for the mutation (c, d)

Discussion

The prevalence of JBTS ranges between 1:80,000 and 1:100,000 [911]. JBTS is genetically heterogeneous with 23 genes identified thus far. We used a whole-genome approach to identify the homozygous loci in this family, followed by a targeted Sanger sequencing of AHI1.

The homozygous p.Thr304AsnfsX6 mutation found in this family was reported in one affected patient from a consanguineous family originating from Spain [12] and in two patients originating from the Netherlands [11] (exon 7 for NM_017651.3). The spanish patient (family MTI-107 in the article) had compound mutations respectively in exon 8 (exon 7 in NM_017651.4) and in exon 14. The p.Thr304AsnfsX6 mutation predicts a prematurely truncated protein. Contrary to what was reported by Kroes et al. [11], this mutation is therefore not specific for the Dutch population.

Most AHI1 mutations reported by Valente et al. [12] and Kroes et al. [11] are truncating, except the two V443D and R723Q missense mutations. Most mutations cluster within exons 7 to 16. The occurrence of the p.Thr304AsnfsX6 mutation in two unrelated families (Moroccan and Spanish) may be due to a founder effect, as reported for many other mutations in patients with JBTS. The c.218 G>T mutation, resulting in p.Arg73Leu in transmembrane protein 216 (TMEM216) has been reported with a founder effect in the Ashkenazi Jewish population [12]. As an Arab population (Moorish or Moriscos) lived in Spain for hundreds years and many converted to Christianity, the presence of the same mutation in Arabic Moroccan and Spanish families with JBTS suggests that they might share the same founder; however, the two other patients from the Netherlands with the same (p.Thr304AsnfsX6) mutation reported by Kroes et al. [11] have a Dutch origin, as well as their parents, as far as several generations back (personal communication by Kroes). To investigate the genetic history of this mutation in the Moroccan, Spanish, and Dutch families with JBTS, the analysis of linkage disequilibrium (LD) between flanking polymorphic markers and AHI locus should shed light on the origin of this mutation and estimate the age of the mutation, that is, whether it was carried by a common ancestor or arose due to a mutational hotspot.

Parisi et al. reported that 11 % of individuals with JBTS had AHI1 mutations [10], Kroes et al. revealed that 16 % of patients with JBTS from the Netherlands had mutations in AHI1 [11], whereas Valente et al. identified mutations in this gene in 7.3 % of individuals in a cohort of patients with JSRDs [12]. Among this large cohort of 137 families with JSRDs and a demonstrated MTS, Valente et al. [12] identified 15 deleterious AHI1 mutations in 10 families with pure JS or JS plus retinal and/or additional central nervous system abnormalities. They reported that no correlate was evident between the type of mutation (truncating, missense, or splicing) or the exon involved and the phenotypes observed [12]. They concluded that AHI1 mutations are a frequent cause of the disease in patients with specific forms of JSRDs but are not responsible for JSRDs with liver and kidney abnormalities. Valente et al. [12] found that AHI1 mutations are a frequent cause of JS with retinal involvement or other central nervous system abnormalities, or both, which is consistent with our report.

Almost 80 % of patients with AHI1 mutations have retinal dystrophy [11, 13] and early onset congenital blindness [12]. The three patients presented here and the two patients reported by Froes et al. [11] carrying the p.Thr304AsnfsX6 mutation showed retinal and oculomotor abnormalities (that is, retinitis pigmentosa or Leber congenital amaurosis, nystagmus). The ocular abnormalities were not observed in the Spanish patient (MTI-107, 10-years old) reported by Valente et al. [12].

Renal disease consistent with NPHP has also been described in patients with JBTS with AHI1 mutations [10, 11]. Renal ultrasound in our three patients did not reveal any abnormalities; renal disease was also absent in the Spanish and Dutch patients with the same p.Thr304AsnfsX6 mutation. However, breathing abnormalities were absent in our affected Moroccan siblings as compared to the Spanish and Dutch patients. Other neurological malformations are found to be variable among these patients with the same mutation.

JSRDs is inherited predominantly in an autosomal recessive manner. X-linked inheritance has been reported in OFD1-related JSRDs. Digenic inheritance has also been suggested. Lee et al. reported a digenism in JBTS, resulting from a heterozygous CEP41 mutation in combination with either a coiled-coil and C2 domain containing 2A (CC2D2A) or a Kinesin family member 7 (KIF7) mutation [14]. Such digenic inheritance has also been suggested in patients with AHI1 mutations and NPHP1 deletions [11]. This observation suggests that NPHP1 deletion leads to a large range of phenotypes that can be modified by AHI1 mutations. The CNV analysis undertaken in our patients did not show any deletion of the NPHP1 gene.

Our study demonstrates that homozygosity mapping is a powerful method to rapidly detect the disease-causing gene especially in clinically and genetically heterogeneous disorders such as JBTS.

Conclusions

In this study we detected a disease-causing mutation in the AHI1 gene in a Moroccan family with JBTS by using homozygosity mapping. The rare p.Thr304AsnfsX6 mutation found in the Moroccan patients has been found in one Spanish patient and in two patients from the Netherlands in a heterozygous state suggesting that they may share the same founder ancestor. This might be more probable between Moroccan and Spanish families because of a common history. The second hypothesis proposes a mutational hotspot. In this study, the result allows accurate genetic counselling and may offer a molecular prenatal diagnosis to this family.

Methods

Sampling and DNA extraction

The Moroccan family was recruited in the Genetics Department of the National Institute of Health, Rabat, Morocco. DNA was extracted from whole blood using the standard protocol for the three affected patients and their parents. Written informed consent for genetic analysis was obtained from the parents for themselves and for their children included in this study, which conforms to the Helsinki Declaration and local legislation.

Linkage analysis and homozygosity mapping

Affected individuals were selected for genome-wide SNP analysis using the high-resolution Affymetrix SNP 6.0 array containing 906,600 polymorphic SNPs and more than 946,000 unique probes for CNV detection. The genotyping of patients and parents was performed according to the manufacturer’s protocol. The regions of homozygosity (ROHs) were detected by the Affymetrix® Chromosome Analysis Suite (ChAS) software.

Mutation analysis

Exons and intron–exon boundaries of AHI1 were sequenced in one proband using 3130 Automated Sequencer (Applied Biosystems, Foster City, CA, USA). We used a touchdown protocol for the polymerase chain reaction (PCR) procedures to amplify all exons in the same conditions. Primer sequences and PCR conditions are available on request.

Consent

Written informed consent was obtained from the family for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this Journal.

Abbreviations

AHI1

Abelson helper integration site 1

CNV: 

Copy number variation

JBTS: 

Joubert syndrome

JSRDs: 

Joubert syndrome and related disorders

MIM: 

Mendelian Inheritance in Man

MRI: 

Magnetic resonance imaging

MTS: 

Molar tooth sign

NPHP: 

Nephronophthisis

NPHP1

Nephronophthisis 1

OFD1: 

Oral-facial-digital syndrome type 1

PCR: 

Polymerase chain reaction

SNP: 

Single nucleotide polymorphism

Declarations

Acknowledgements

We acknowledge the CNRS (Centre National de Recherche Scientifique, France) and CNRST (Centre National de Recherche Scientifique, Morocco) convention for supporting this project.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Département de Génétique Médicale, Institut National d’Hygiène
(2)
Centre de Génomique Humaine, Faculté de Médecine et de Pharmacie, Université Mohammed V Souissi
(3)
Université d’Orléans & CNRS, INEM-UMR7355, Immunologie Expérimentale et Moléculaire & Neurogénétique
(4)
Service d’Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, AP-HP
(5)
Service de Pédiatrie IIA, Hôpital d’Enfants
(6)
Université Paris Descartes, Sorbonne Paris Cité, France, Institut IMAGINE
(7)
INSERM UMR1163, Paris Descartes – Sorbonne Paris Cité University, Imagine Institute
(8)
Centre Hospitalier Régional d’Orléans (CHRO), Pôle de Biopathologie

References

  1. Joubert M, Eisenring JJ, Robb JP, Andermann F. Familial agenesis of the cerebellar vermis. Neurology. 1969;19:813–25.View ArticlePubMedGoogle Scholar
  2. Saraiva JM, Baraitser M. Joubert syndrome: a review. Am J Med Genet. 1992;43:726–31.View ArticlePubMedGoogle Scholar
  3. Satran D, Pierpont ME, Dobyns WB. Cerebello-oculo-renal syndromes including Arima, Senior-Löken and COACH syndromes: more than just variants of Joubert syndrome. Am J Med Gene. 1999;86:459–69.View ArticleGoogle Scholar
  4. Valente EM, Silhavy JL, Brancati F, Barrano G, Krishnaswami SR, Castori M, et al. Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. Nat Genet. 2006;38:623–5.View ArticlePubMedGoogle Scholar
  5. Parisi MA. Clinical and molecular features of Joubert syndrome and related disorders. Am J Med Genet C Semin Med Genet. 2009;151C:326–40.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Baala L, Audollent S, Martinovic J, Ozilou C, Babron MC, Sivanandamoorthy S, et al. Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome. Am J Hum Genet. 2007;81:170–9.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Delous M, Baala L, Salomon R, Laclef C, Vierkotten J, Tory K, et al. The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat Genet. 2007;39:875–81.View ArticlePubMedGoogle Scholar
  8. Huang L, Szymanska K, Jensen VL, Janecke AR, Innes AM, Davis EE, et al. TMEM237 is mutated in individuals with a Joubert syndrome related disorder and expands the role of the TMEM family at the ciliary transition zone. Am J Hum Genet. 2011;89:713–30.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Brancati F, Dallapiccola B, Valente EM. Joubert Syndrome and related disorders. Orphanet J Rare Dis. 2010;5:20.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Parisi MA, Doherty D, Eckert ML, Shaw DW, Ozyurek H, Aysun S, et al. AHI1 mutations cause both retinal dystrophy and renal cystic disease in Joubert syndrome. J Med Genet. 2006;43:334–9.View ArticlePubMedGoogle Scholar
  11. Kroes HY, van Zon PH, Fransen van de Putte D, Nelen MR, Nievelstein RJ, Wittebol-Post D, et al. DNA analysis of AHI1, NPHP1 and CYCLIN D1 in Joubert syndrome patients from the Netherlands. Eur J Med Genet. 2008;51:24–34.View ArticlePubMedGoogle Scholar
  12. Valente EM, Brancati F, Silhavy JL, Castori M, Marsh SE, Barrano G, et al. AHI1 gene mutations cause specific forms of Joubert syndrome-related disorders. Ann Neurol. 2006;59:527–34.View ArticlePubMedGoogle Scholar
  13. Valente EM, Brancati F, Dallapiccola B. Genotypes and phenotypes of Joubert syndrome and related disorders. Eur J Med Genet. 2008;51:1–23.View ArticlePubMedGoogle Scholar
  14. Lee JE, Silhavy JL, Zaki MS, Schroth J, Bielas SL, Marsh SE, et al. CEP41 is mutated in Joubert syndrome and is required for tubulin glutamylation at the cilium. Nat Genet. 2012;44:193–9.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Chafai-Elalaoui et al. 2015

Advertisement